Danilo Wegner

701 total citations
19 papers, 582 citations indexed

About

Danilo Wegner is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Danilo Wegner has authored 19 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in Danilo Wegner's work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Gastroesophageal reflux and treatments (4 papers). Danilo Wegner is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Gastroesophageal reflux and treatments (4 papers). Danilo Wegner collaborates with scholars based in Germany, United States and South Korea. Danilo Wegner's co-authors include Werner Siegmund, Christiane Modeß, Thomas Gießmann, Werner Weitschies, M Zschiesche, Stefan Oswald, Ingolf Cascorbi, R Warzok, Sierk Haenisch and Peter Dazert and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Danilo Wegner

19 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danilo Wegner Germany	12	328	198	123	120	91	19	582
Sarah Shugarts United States	9	259 0.8×	119 0.6×	134 1.1×	130 1.1×	76 0.8×	13	691
Ingrid Fricke-Galindo Mexico	14	130 0.4×	145 0.7×	181 1.5×	119 1.0×	194 2.1×	41	720
Chantal Barin‐Le Guellec France	14	128 0.4×	114 0.6×	79 0.6×	115 1.0×	64 0.7×	36	545
In‐Jin Jang South Korea	14	153 0.5×	123 0.6×	222 1.8×	105 0.9×	100 1.1×	27	660
Kaoru Ueda Japan	11	338 1.0×	163 0.8×	376 3.1×	91 0.8×	72 0.8×	33	760
Michael J. Knauer Canada	12	191 0.6×	101 0.5×	92 0.7×	94 0.8×	118 1.3×	25	603
Landry K. Kamdem United States	12	338 1.0×	229 1.2×	326 2.7×	162 1.4×	64 0.7×	21	898
Nassim Djebli France	14	158 0.5×	166 0.8×	155 1.3×	125 1.0×	65 0.7×	30	678
Alice Ke United States	16	208 0.6×	240 1.2×	228 1.9×	138 1.1×	81 0.9×	30	755
Mikael S. Thomsen Denmark	14	172 0.5×	94 0.5×	304 2.5×	129 1.1×	47 0.5×	25	751

Countries citing papers authored by Danilo Wegner

Since Specialization

Citations

This map shows the geographic impact of Danilo Wegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Wegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Wegner more than expected).

Fields of papers citing papers by Danilo Wegner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danilo Wegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Wegner. The network helps show where Danilo Wegner may publish in the future.

Co-authorship network of co-authors of Danilo Wegner

This figure shows the co-authorship network connecting the top 25 collaborators of Danilo Wegner. A scholar is included among the top collaborators of Danilo Wegner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danilo Wegner. Danilo Wegner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Weiß, Michael, Christiane Modeß, Danilo Wegner, et al.. (2019). Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects. The Journal of Clinical Pharmacology. 60(3). 312–323. 10 indexed citations

Weiß, Michael, Christiane Modeß, Danilo Wegner, et al.. (2019). Effects of the P‐Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4‐Way Crossover Drug‐Drug Interaction Study in Healthy Subjects. The Journal of Clinical Pharmacology. 59(10). 1319–1330. 6 indexed citations

Bruckmueller, Henrike, Danilo Wegner, Diana Busch, et al.. (2019). Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine. Molecular Pharmaceutics. 16(9). 3823–3830. 27 indexed citations

Moritz, Eileen, Danilo Wegner, Stefan Groß, et al.. (2017). Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania. Data in Brief. 12. 46–50. 7 indexed citations

Moritz, Eileen, Danilo Wegner, Stefan Groß, et al.. (2017). Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania. Clinica Chimica Acta. 468. 25–31. 25 indexed citations

Scheuch, Eberhard, Stefan Oswald, Mahmoud Hasan, et al.. (2017). Intestinal and hepatic contributions to the pharmacokinetic interaction between gamithromycin and rifampicin after single‐dose and multiple‐dose administration in healthy foals. Equine Veterinary Journal. 50(4). 525–531. 2 indexed citations

Siebert, Nikolai, Diana Seidel, Danilo Wegner, et al.. (2016). Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2. mAbs. 8(3). 604–616. 44 indexed citations

Weiß, Michael, Christiane Modeß, Danilo Wegner, et al.. (2016). Trospium chloride is absorbed from two intestinal “absorption windows” with different permeability in healthy subjects. International Journal of Pharmaceutics. 515(1-2). 367–373. 11 indexed citations

Modeß, Christiane, et al.. (2015). Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects. The Journal of Clinical Pharmacology. 56(2). 239–245. 15 indexed citations

10.

Gunzburg, Jean de, Annie Ducher, Christiane Modeß, et al.. (2014). Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects. The Journal of Clinical Pharmacology. 55(1). 10–16. 59 indexed citations

11.

Kretzschmar, Albrecht, et al.. (2012). Gastroduodenal ulceration after selective internal radiation therapy of liver tumor. Endoscopy. 44(S 02). E354–E355. 3 indexed citations

12.

May, Karen, Thomas Gießmann, Danilo Wegner, et al.. (2008). Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination. European Journal of Clinical Pharmacology. 64(11). 1085–1092. 13 indexed citations

13.

May, Karen, Kristin Westphal, Thomas Gießmann, et al.. (2008). Disposition and Antimuscarinic Effects of the Urinary Bladder Spasmolytics Propiverine: Influence of Dosage Forms and Circadian‐Time Rhythms. The Journal of Clinical Pharmacology. 48(5). 570–579. 12 indexed citations

14.

Haenisch, Sierk, Karen May, Danilo Wegner, et al.. (2008). Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol. Pharmacogenetics and Genomics. 18(4). 357–365. 73 indexed citations

15.

Gießmann, Thomas, Christiane Modeß, Danilo Wegner, et al.. (2006). Simvastatin does not influence the intestinal P‐glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms. British Journal of Clinical Pharmacology. 61(4). 440–450. 35 indexed citations

16.

Oswald, Stefan, Thomas Gießmann, Danilo Wegner, et al.. (2006). Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins. Clinical Pharmacology & Therapeutics. 80(5). 477–485. 37 indexed citations

17.

Weitschies, Werner, Thomas Gießmann, M Zschiesche, et al.. (2005). The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen. Pharmaceutical Research. 22(5). 728–735. 56 indexed citations

18.

Gießmann, Thomas, K. May, Christiane Modeß, et al.. (2004). Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clinical Pharmacology & Therapeutics. 76(3). 192–200. 146 indexed citations

19.

Wegner, Danilo, et al.. (1987). [Secretin-pancreozymin test with volume correction in the functional diagnosis of pancreatobiliary secretion].. PubMed. 47(5). 242–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact